“Profile of Sales and Notifications of Suspected Adverse Events Related to Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic”. Research, Society and Development 12, no. 2 (January 30, 2023): e15112240021. Accessed February 5, 2026. https://rsdjournal.org/rsd/article/view/40021.